1. Foucar K, Langdon RM II, Armitage JO, et al. Myelodysplastic syndromes: a clinical and pathologic analysis of 109 cases. Cancer. 1985; 56:553-561.
2. Kerkhofs H, Hermanns J, Haak HL, et al. Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. Br J Haematol. 1987; 65:73-81.
3. Economopoulos T, Stathakis N, Foudoulakis A, et al. Myelodysplastic syndromes: analysis of 131 cases according to the FAB classification. Eur J Haematol. 1987; 38:338-344.
4. Germing U, Gattermann N, Strupp C, et al. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leuk Res. 2000; 24:983-992.
5. Howe RB, Porwit-MacDonald A, Wanat R, et al. The WHO Classification of MDS does make a difference. Blood. 2004; 103:3265-3270.